Full Text
HPR17 National Reimbursement Drug List in China: Changing Dynamics and Trend and Price Determination of Formulation Innovation Drugs

Abstract

Authors

J Qiu C Zuo Y Chen X Peng S Wu W Zhao H Bi J Xuan

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×